Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment
Status:
Completed
Trial end date:
2019-12-15
Target enrollment:
Participant gender:
Summary
This open-label study will evaluate hydroxyzine, a first-generation antihistamine, combined
with varenicline, to help smokers abstain from smoking during a 12-week trial period by
diminishing the nausea, stress, anxiety, and sleep disturbances associated with the use of
varenicline and with nicotine withdrawal.